The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Monoclonal antibodies inhibit prion replication and delay the development of prion disease
Open accessAbstract
Prion diseases such as Creutzfeldt-Jakob disease (CJD) are fatal, neuro-degenerative disorders with no known therapy. A proportion of the UK population has been exposed to a bovine spongiform encephalopathy-like prion strain and are at risk of developing variant CJD. A hallmark of prion disease is the transformation of normal cellular prion protein (PrP(C)) into an infectious disease-associated isoform, PrP(Sc). Recent in vitro studies indicate that anti-PrP monoclonal antibodies with little or no affinity for PrP(Sc) can prevent the incorporation of PrP(C) into propagating prions. We therefore investigated in a murine scrapie model whether anti-PrP monoclonal antibodies show similar inhibitory effects on prion replication in vivo. We found that peripheral PrP(Sc) levels and prion infectivity were markedly reduced, even when the antibodies were first administered at the point of near maximal accumulation of PrP(Sc) in the spleen. Furthermore, animals in which the treatment was continued remained healthy for over 300 days after equivalent untreated animals had succumbed to the disease. These findings indicate that immunotherapeutic strategies for human prion diseases are worth pursuing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
A new variant of Creutzfeldt-Jakob disease in the UK
Will, R. G., Ironside, J. W., Zeidler, M., Estibeiro, K., Cousens, S. N., Smith, P. G., Alperovitch, A., Poser, S., Pocchiari, M., & Hofman, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91412-9 · Cited by 2,707
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent
Bruce, M. E., Will, R. G., Ironside, J. W., McConnell, I., Drummond, D., Suttie, A., McCardle, L., Chree, A., Hope, J., Birkett, C., et al. (1997) · Nature · doi:10.1038/39057 · Cited by 1,967
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J., & Hill, A. F. (1996) · Nature · doi:10.1038/383685a0 · Cited by 1,735
Self-citationNormal development and behaviour of mice lacking the neuronal cell-surface PrP protein
Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M., & Weissmann, C. (1992) · Nature · doi:10.1038/356577a0 · Cited by 1,655
The same prion strain causes vCJD and BSE
Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. C. L., Gowland, I., Collinge, J., Doey, L. J., & Lantos, P. (1997) · Nature · doi:10.1038/38925 · Cited by 1,456
Self-citationNormal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 810
Self-citationWadsworth, J., Joiner, S., Hill, A., Campbell, T., Desbruslais, M., Luthert, P., & Collinge, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05403-4 · Cited by 693
Self-citationAntibodies inhibit prion propagation and clear cell cultures of prion infectivity
Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R., Rudd, P. M., et al. (2001) · Nature · doi:10.1038/35089090 · Cited by 525
Dickinson, A. G., Meikle, V. M. H., & Fraser, H. (1968) · Journal of Comparative Pathology · doi:10.1016/0021-9975(68)90005-4 · Cited by 428
Enari, M., Flechsig, E., & Weissmann, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151242598 · Cited by 427
Reversible Conversion of Monomeric Human Prion Protein Between Native and Fibrilogenic Conformations
Jackson, G. S., Hosszu, L. L. P., Power, A., Hill, A. F., Kenney, J., Saibil, H., Craven, C. J., Waltho, J. P., Clarke, A. R., & Collinge, J. (1999) · Science · doi:10.1126/science.283.5409.1935 · Cited by 364
Self-citationBrown, K. L., Stewart, K., Ritchie, D. L., Mabbott, N. A., Williams, A., Fraser, H., Morrison, W. I., & Bruce, M. E. (1999) · Nature Medicine · doi:10.1038/15264 · Cited by 363
Impaired Prion Replication in Spleens of Mice Lacking Functional Follicular Dendritic Cells
Montrasio, F., Frigg, R., Glatzel, M., Klein, M. A., Mackay, F., Aguzzi, A., & Weissmann, C. (2000) · Science · doi:10.1126/science.288.5469.1257 · Cited by 357
Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies
Heppner, F. L., Musahl, C., Arrighi, I., Klein, M. A., Rülicke, T., Oesch, B., Zinkernagel, R. M., Kalinke, U., & Aguzzi, A. (2001) · Science · doi:10.1126/science.1063093 · Cited by 346
PrP expression in B lymphocytes is not required for prion neuroinvasion
Klein, M. A., Frigg, R., Raeber, A. J., Flechsig, E., Hegyi, I., Zinkernagel, R. M., Weissmann, C., & Aguzzi, A. (1998) · Nature Medicine · doi:10.1038/4022 · Cited by 266
Immunization Delays the Onset of Prion Disease in Mice
Sigurdsson, E. M., Brown, D. R., Daniels, M., Kascsak, R. J., Kascsak, R., Carp, R., Meeker, H. C., Frangione, B., & Wisniewski, T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64151-x · Cited by 190
Congo red prolongs the incubation period in scrapie-infected hamsters
Ingrosso, L., Ladogana, A., & Pocchiari, M. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.506-508.1995 · Cited by 160
Regional heterogeneity of cellular prion protein isoforms in the mouse brain
Béringue, V. (2003) · Brain · doi:10.1093/brain/awg205 · Cited by 142
Postexposure prophylaxis against prion disease with a stimulator of innate immunity.
Sethi, S., Lipford, G., Wagner, H., & Kretzschmar, H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09513-2 · Cited by 138
Multiple folding pathways for heterologously expressed human prion protein
Jackson, G. S., Hill, A. F., Joseph, C., Hosszu, L. L. P., Power, A., Waltho, J. P., Clarke, A. R., & Collinge, J. (1999) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00038-2 · Cited by 125
Self-citationModulation of proteinase-K resistant prion protein by prion peptide immunization
Souan, L., Tal, Y., Felling, Y., Cohen, I. R., Taraboulos, A., & Mor, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2338::aid-immu2338>3.0.co;2-v · Cited by 80
Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection
McKenzie, D. I., Kaczkowski, J., Marsh, R., & Aiken, J. M. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7534-7536.1994 · Cited by 62
Drug therapy in human and experimental transmissible spongiform encephalopathy
Brown, P. (2002) · Neurology · doi:10.1212/wnl.58.12.1720 · Cited by 50
Mammalian prion proteins: enigma, variation and vaccination
Westaway, D. A., & Carlson, G. A. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02106-0 · Cited by 24
Cited by
Therapeutic approaches to protein-misfolding diseases
Cohen, F. E., & Kelly, J. W. (2003) · Nature · doi:10.1038/nature02265 · Cited by 800
Protein aggregation diseases: pathogenicity and therapeutic perspectives
Aguzzi, A., & O'Connor, T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3050 · Cited by 762
Aguzzi, A., & Polymenidou, M. (2004) · Cell · doi:10.1016/s0092-8674(03)01031-6 · Cited by 544
Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease
Masliah, E., Rockenstein, E., Adame, A., Alford, M., Crews, L., Hashimoto, M., Seubert, P., Lee, M., Goldstein, J., Chilcote, T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.010 · Cited by 542
Prions: Protein Aggregation and Infectious Diseases
Aguzzi, A., & Calella, A. M. (2009) · Physiological Reviews · doi:10.1152/physrev.00006.2009 · Cited by 504
Metadata
- Authors
- White, A. R., Enever, P., Tayebi, M., Mushens, R., Linehan, J., Brandner, S., Anstee, D., Collinge, J., & Hawke, S.
- Venue
- Nature
- Published
- 2003-03
- Volume
- 422
- Issue
- 6927
- Pages
- 80-83
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2063553621
- Cited by
- 492
- References
- 26
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.